Neuropharmacology

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means.

Publisher: Elsevier
Website: http://www.journals.elsevier.com/neuropharmacology/
Impact factor: 4.137 (2011)

Some content from Wikipedia, licensed under CC BY-SA

Medications

Insomnia drug helps prevent oxycodone relapse, study shows

A good night's sleep has many proven health benefits, and a new Scripps Research study suggests one more: preventing opioid relapse.

Sep 6, 2023

Medical research

Blocking glutamate release reduces oxycodone intake and seeking behavior

Over the last decade, opioid abuse and overdoses have reached epidemic proportions in the United States. Now, Scripps Research scientists show that a drug that activates metabotropic glutamate 2 receptors in the brain can ...

Jul 27, 2023

Neuroscience

Mouse models of adolescent binge drinking reveal key long-lasting brain changes

Heavy alcohol consumption may cause permanent dysregulation of neurons, or brain cells, in adolescents, according to a new study in mice. The findings suggest that exposure to binge-levels of alcohol during adolescence, when ...

Jun 9, 2023

Medications

Anti-depressant agent KNT-127 found to reduce stress as well as depression

Depression due to psychological stress affects millions of people worldwide. However, most of the existing anti-depressant drugs are slow, prone to development of resistance, and have severe side effects, demanding the need ...

May 8, 2023

Medical research

Coffee and cigarettes: Research sheds new light on nicotine and morning brew

For some smokers, the first cigarette of the day is just not as satisfying without a cup of coffee. That could be more than just a morning habit: Chemical compounds in roasted coffee beans may help lighten the effects of ...

Aug 17, 2022

HIV & AIDS

Changes in the brain hinder addiction recovery in people who are HIV-positive

Researchers with the Del Monte Institute for Neuroscience at the University of Rochester are studying how the brain puts the 'brakes' on behavior. That may be different in individuals recovering from cocaine addiction and ...

Dec 21, 2021

Medications

Search for safer pain relief advances with new compounds

Scientists at Scripps Research in Florida have created a collection of new pain-relieving compounds, that like morphine and other drugs, provide relief via activation of opioid receptors, but without inducing many dangerous ...

Nov 22, 2021

Neuroscience

Study shows fragile X treatment can incur resistance, suggests ways around it

Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder—fragile X syndrome—might be treated with drugs that inhibit a neurotransmitter ...

Sep 29, 2021

Medications

Neuroscientists discover possible treatment for victims of chemical warfare

What do pest control, agricultural workers and members of the armed forces have in common? These three important groups are all at increased risk of toxic exposure to organophosphates.

Sep 16, 2021